When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Swedish Orphan Biovitrum AB (OTCPK:BIOVF) has entered into an agreement to sell a FDA Priority Review Voucher (PRV) to AstraZeneca for a total cash consideration of $95M.
More news on: Swedish Orphan Biovitrum AB (publ), Healthcare stocks news,